Quarterly report pursuant to Section 13 or 15(d)

Stock Plans (Tables)

v3.24.4
Stock Plans (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of our option activity
Schedule of our option activity                                
    Options
(in thousands)
    Weighted
Average
Exercise
Price
per share
    Weighted
Average
Remaining
Option Term
(in years)
    Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding at December 31, 2023     93     $ 73.46       8.35     $ -  
Outstanding at September 30, 2024     93       71.75       7.29       -  
Exercisable at September 30, 2024     93       71.75       7.29       -  
Schedule of the stock-based compensation expense
Schedule of the stock-based compensation expense                                
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
(in thousands of U.S. dollars)   2024     2023     2024     2023  
Research and development   $ -     $ 52     $ -     $ 106  
Selling, general and administrative     -       359       -       859  
Total stock-based compensation   $ -      $ 411     $ -     $ 965